Department of Neurosurgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea
Copyright © 2020 The Korean Society of Trauma
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
| Total (n=82) | No recurrence (n=67; 81.7%) | Recurrence (n=15; 18.3%) | p-value | |
|---|---|---|---|---|
| Sex (male) | 60 (73.2) | 50 (74.6) | 10 (66.7) | 0.532 |
| Age | 70.2±12.1 | 70.2±12.0 | 70.1±13.4 | 0.986 |
| Head trauma history | 51 (62.2) | 43 (64.2) | 8 (53.3) | 0.434 |
| History | ||||
| Hypertension | 50 (61.0) | 39 (58.2) | 11 (73.3) | 0.278 |
| Diabetes mellitus | 20 (24.4) | 18 (26.9) | 2 (13.3) | 0.339 |
| Hyperlipidemia | 11 (13.4) | 8 (11.9) | 3 (20.0) | 0.414 |
| CRF | 4 (4.9) | 3 (4.5) | 1 (6.7) | 0.562 |
| Heart disease | 8 (9.8) | 6 (9.0) | 2 (13.3) | 0.634 |
| Liver disease | 4 (4.9) | 3 (4.5) | 1 (6.7) | 0.562 |
| Alcoholism | 21 (25.6) | 18 (26.9) | 3 (20.0) | 0.749 |
| Smoking | 18 (22.0) | 17 (25.4) | 1 (6.7) | 0.171 |
| Coagulopathya | 6 (7.3) | 5 (7.5) | 1 (6.7) | 1.000 |
| Antiplatelet medication | 22 (26.8) | 14 (20.9) | 8 (53.3) | 0.021 |
| Dementia | 3 (3.7) | 2 (3.0) | 1 (6.7) | 0.459 |
| Preoperative GCS | 13.8±2.5 | 13.9±2.6 | 13.5±2.4 | 0.665 |
| 15–14 | 61 (74.4) | 52 (77.6) | 9 (60.0) | 0.194 |
| 13–9 | 13 (15.9) | 9 (13.4) | 4 (26.7) | 0.243 |
| 8–3 | 8 (9.8) | 6 (9.0) | 2 (13.3) | 0.634 |
| Bilateral lesion | 31 (37.8) | 23 (34.3) | 8 (53.3) | 0.170 |
| Computed tomography findings | ||||
| Preoperative homogenous hematoma | 35 (43.2) | 29 (43.9) | 6 (40.0) | 0.781 |
| H/N in homogenous hematoma | 36.3±10.9 | 35.6±11.5 | 40.0±6.3 | 0.373 |
| Preoperative hematoma thickness | 20.7±6.6 | 20.8±6.7 | 20.2±6.3 | 0.750 |
| Postoperative hematoma thickness | 11.2±5.4 | 11.1±5.6 | 11.7±4.6 | 0.700 |
| Prognosis using GOS | 4.7±0.75 | 4.8±0.74 | 4.6±0.83 | 0.458 |
| 5–4 (good) | 79 (96.3) | 65 (97.0) | 14 (93.3) | 0.459 |
| 3–1 (poor) | 3 (3.7) | 2 (3.0) | 1 (6.7) | 0.459 |
| Operation methods | ||||
| Single burr-hole (group A) | 47 (57.3) | 35 (52.2) | 12 (80.0) | 0.049 |
| Single burr-hole irrigation (group B) | 14 (17.1) | 13 (19.4) | 1 (6.7) | 0.448 |
| Double burr-hole irrigation (group C) | 21 (25.6) | 19 (28.4) | 2 (13.3) | 0.332 |
| Crude OR (95% CI) | Adjusted ORa (95% CI) | Adjusted ORb (95% CI) | |
|---|---|---|---|
| Irrigation | 0.06 (0.07–1.06) | 0.29 (0.07–1.16) | 0.20 (0.04–0.97) |
| Two burr-holes | 0.39 (0.08–1.89) | 0.41 (0.08–2.06) | 0.38 (0.60–2.38) |
| Total (n=82) | No recurrence (n=67; 81.7%) | Recurrence (n=15; 18.3%) | p-value | |
|---|---|---|---|---|
| Sex (male) | 60 (73.2) | 50 (74.6) | 10 (66.7) | 0.532 |
| Age | 70.2±12.1 | 70.2±12.0 | 70.1±13.4 | 0.986 |
| Head trauma history | 51 (62.2) | 43 (64.2) | 8 (53.3) | 0.434 |
| History | ||||
| Hypertension | 50 (61.0) | 39 (58.2) | 11 (73.3) | 0.278 |
| Diabetes mellitus | 20 (24.4) | 18 (26.9) | 2 (13.3) | 0.339 |
| Hyperlipidemia | 11 (13.4) | 8 (11.9) | 3 (20.0) | 0.414 |
| CRF | 4 (4.9) | 3 (4.5) | 1 (6.7) | 0.562 |
| Heart disease | 8 (9.8) | 6 (9.0) | 2 (13.3) | 0.634 |
| Liver disease | 4 (4.9) | 3 (4.5) | 1 (6.7) | 0.562 |
| Alcoholism | 21 (25.6) | 18 (26.9) | 3 (20.0) | 0.749 |
| Smoking | 18 (22.0) | 17 (25.4) | 1 (6.7) | 0.171 |
| Coagulopathy |
6 (7.3) | 5 (7.5) | 1 (6.7) | 1.000 |
| Antiplatelet medication | 22 (26.8) | 14 (20.9) | 8 (53.3) | 0.021 |
| Dementia | 3 (3.7) | 2 (3.0) | 1 (6.7) | 0.459 |
| Preoperative GCS | 13.8±2.5 | 13.9±2.6 | 13.5±2.4 | 0.665 |
| 15–14 | 61 (74.4) | 52 (77.6) | 9 (60.0) | 0.194 |
| 13–9 | 13 (15.9) | 9 (13.4) | 4 (26.7) | 0.243 |
| 8–3 | 8 (9.8) | 6 (9.0) | 2 (13.3) | 0.634 |
| Bilateral lesion | 31 (37.8) | 23 (34.3) | 8 (53.3) | 0.170 |
| Computed tomography findings | ||||
| Preoperative homogenous hematoma | 35 (43.2) | 29 (43.9) | 6 (40.0) | 0.781 |
| H/N in homogenous hematoma | 36.3±10.9 | 35.6±11.5 | 40.0±6.3 | 0.373 |
| Preoperative hematoma thickness | 20.7±6.6 | 20.8±6.7 | 20.2±6.3 | 0.750 |
| Postoperative hematoma thickness | 11.2±5.4 | 11.1±5.6 | 11.7±4.6 | 0.700 |
| Prognosis using GOS | 4.7±0.75 | 4.8±0.74 | 4.6±0.83 | 0.458 |
| 5–4 (good) | 79 (96.3) | 65 (97.0) | 14 (93.3) | 0.459 |
| 3–1 (poor) | 3 (3.7) | 2 (3.0) | 1 (6.7) | 0.459 |
| Operation methods | ||||
| Single burr-hole (group A) | 47 (57.3) | 35 (52.2) | 12 (80.0) | 0.049 |
| Single burr-hole irrigation (group B) | 14 (17.1) | 13 (19.4) | 1 (6.7) | 0.448 |
| Double burr-hole irrigation (group C) | 21 (25.6) | 19 (28.4) | 2 (13.3) | 0.332 |
| Group A (n=47) | Group B (n=14) | Group C (n=21) | p-value | |
|---|---|---|---|---|
| Sex (male) | 32 (68.2) | 10 (71.4) | 18 (85.7) | 0.145 |
| Age | 68.3±13.1 | 72.2±7.8 | 73.1±11.8 | 0.254 |
| Antiplatelet medication | 12 (25.5) | 6 (42.9) | 4 (19.0) | 0.766 |
| Preoperative homogenous hematoma | 18 (39.1) | 8 (57.1) | 9 (42.9) | 0.639 |
| Preoperative GCS | 13.7±2.6 | 13.9±3.2 | 13.8±2.1 | 0.972 |
| 15–14 | 34 (72.3) | 12 (85.7) | 15 (71.4) | 0.920 |
| 13–9 | 8 (17.0) | 1 (7.1) | 4 (19.0) | 0.966 |
| 8–3 | 5 (10.6) | 1 (7.1) | 2 (9.5) | 0.841 |
| Recurrence | 12 (25.5) | 1 (7.1) | 2 (9.5) | 0.081 |
| One burr-hole (A, B) (n=61) | Two burr-holes (C) (n=21) | p-value | |
|---|---|---|---|
| Recurrence | 13 (21.3) | 2 (9.5) | 0.332 |
| Antiplatelet medication | 18 (29.5) | 4 (19.0) | 0.351 |
| Outcome | |||
| Good | 58 (95.1) | 21 (100.0) | 0.566 |
| Poor | 3 (4.9) | 0 (0) | 0.566 |
| Non-irrigation (A) (n=47) | Irrigation (B, C) (n=35) | p-value | |
|---|---|---|---|
| Recurrence | 12 (25.5) | 3 (8.6) | 0.049 |
| Antiplatelet medication | 12 (25.5) | 10 (28.6) | 0.759 |
| Outcome | |||
| Good | 45 (95.7) | 34 (97.1) | 1.000 |
| Poor | 2 (4.3) | 1 (2.9) | 1.000 |
| Crude OR (95% CI) | Adjusted OR |
Adjusted OR |
|
|---|---|---|---|
| Irrigation | 0.06 (0.07–1.06) | 0.29 (0.07–1.16) | 0.20 (0.04–0.97) |
| Two burr-holes | 0.39 (0.08–1.89) | 0.41 (0.08–2.06) | 0.38 (0.60–2.38) |
Values are presented as mean±standard deviation or number (%). CRF: chronic renal failure, GCS: Glasgow Coma Scale, H/N: Hounsfield unit number, GOS: Glasgow Outcome Scale. Coagulopathy was defined by laboratory values (elevated prothrombin or partial thromboplastin time and thrombocytopenia).
Values are presented as mean±standard deviation or number (%). GCS: Glasgow Coma Scale.
Values are presented as number (%).
Values are presented as number (%).
OR: odds ratio, CSDH: chronic subdural hematoma, CI: confidence interval. Adjusted for age, sex, alcoholism, and smoking. Adjusted for age, sex, alcoholism, smoking, hypertension, diabetes mellitus, liver disease, and antiplatelet medication.